secwatch.observer — SEC 8-K summary
======================================

Issuer:     Opus Genetics, Inc. (IRD)
CIK:        0001228627
Form:       8-K
Filed at:   2025-03-24T23:59:59+00:00
Accession:  0001140361-25-010064
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Opus Genetics closes $20M public stock/warrant offering; CEO & chairman buy $1.5M unit
--------------------------------------------------------------------------------

- Public offering of 12,219,736 units (share + warrant) at $0.95/unit plus 8,832,895 pre-funded warrants at $0.9499; gross proceeds ~$20M.
- Private placement: 1,176,471 shares and warrants at $1.275/unit to CEO Dr. George Magrath and chairman Cam Gallagher.
- Public warrants exercisable at $0.95, private at $1.15; both 5-year terms, callable after OPGx-BEST1 Cohort 1 data and VWAP conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1228627/000114036125010064/0001140361-25-010064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1228627/000114036125010064/ef20045985_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-010064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer